Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents
- 990 Downloads
While N-heterocyclic carbenes (NHC) are ubiquitous ligands in catalysis for organic or industrial syntheses, their potential to form transition metal complexes for medicinal applications has still to be exploited. Within this frame, we synthesized new homo- and heterobimetallic complexes based on the Au(I)–NHC scaffold. The compounds were synthesized via a microwave-assisted method developed in our laboratories using Au(I)–NHC complexes carrying a pentafluorophenol ester moiety and another Au(I) phosphane complex or a bipyridine ligand bearing a pendant amine function. Thus, we developed two different methods to prepare homo- and heterobimetallic complexes (Au(I)/Au(I) or Au(I)/Cu(II), Au(I)/Ru(II), respectively). All the compounds were fully characterized by several spectroscopic techniques including far infrared, and were tested for their antiproliferative effects in a series of human cancer cells. They showed moderate anticancer properties. Their toxic effects were also studied ex vivo using the precision-cut tissue slices (PCTS) technique and initial results concerning their reactivity with the seleno-enzyme thioredoxin reductase were obtained.
KeywordsN-heterocyclic carbene Bimetallic complex Gold complex Anticancer drug Thioredoxin reductase
The “Centre National de la Recherche Scientifique” (ICMUB, UMR CNRS 6302) is gratefully thanked for financial support. Support was provided by the CNRS, the “Université de Bourgogne” and the “Conseil Régional de Bourgogne” through the 3MIM integrated project (“Marquage de Molécules par les Métaux pour l’Imagerie Médicale”) and PARI SSTIC n°6. Dr. Fanny Picquet, Marie-José Penouilh, and Marcel Soustelle are warmly acknowledged for technical support. E. B. is thankful for COST Action TD1004 financial support. A. C. thanks the University of Groningen for funding (Rosalind Franklin Fellowship). Authors are indebted to EU COST Actions CM1105 and CM1106 for stimulating discussion. M. P. R. acknowledges PRIN 20107Z8XBW granted by the Ministero dell’Istruzione, Università e Ricerca (MIUR) (Italy), CPDA130272 granted by the University of Padova (Italy), and Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCSMB).
- 4.Vessieres A, Top S, Beck W, Hillard E, Jaouen G (2006) Dalton Trans:529–541. doi: 10.1039/B509984F
- 15.See for examples of clinical trials in progress in 2014–2015. https://clinicaltrials.gov/ct2/show/NCT01747798, https://clinicaltrials.gov/ct2/show/NCT01419691, http://www.cancer.gov/clinicaltrials/search/view?cdrid=743608&version=HealthProfessional#StudyIdInfo_CD0000743608. Accessed 20 July 2015
- 22.Bagowski CP, You Y, Scheffler H, Vlecken DH, Schmitz DJ, Ott I (2009) Dalton Trans:10799–10805Google Scholar
- 24.Baker MV, Barnard PJ, Berners-Price SJ, Brayshaw SK, Hickley JL, Skelton BW, White AH (2006) Dalton Trans:3708–3715Google Scholar